Lincoln Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA931050
EBIT85970
Earning Per Share313436
Expenses337377421
Net Profit626973
Net Profit Margin151514
Operating Profit Margin222222
Profit Before Tax8496100
Dividends Per Share220
Operation Revenue430482533

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
202300377.40NA868.45
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Lincoln Pharma is 0 as of 6/4/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities2753756976
Investing Activities-12-18-31-64-78
Financing Activities-11-36-38-6-3
Others00000
Net Cash Flow3-17-1-5

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20201,392.41-783.52-444.66164.23
20201,468.841,106.99-890.581,685.25
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Lincoln Pharma is 76 as of 6/4/2023